RecruitingNot ApplicableNCT05631756

Correlation Between PaO2/FiO2 and Lung Ultrasound Score in the Intensive Care Unit

"Correlation Between PaO2/FiO2 and Lung Ultrasound Score in Patients Admitted to an Intensive Care Unit With Interstitial Syndrome: A Prospective Physiological Study"


Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Enrollment

86 participants

Start Date

Jan 26, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this physiological interventional prospective study is to evaluate the improvement of the previously demonstrated correlation between PaO2/ FiO2 and Lung Ultrasound score (LUSS) in patients admitted in the ICU with an intesrtitial syndrom (IS) on the ultrasound of all aetiologies at inclusion and at twenty four and forty eight hours. The main question it aims to answer is if the LUSS is a valid tool to evaluate the severity of the IS Participants will initially have an arterial blood gas to evaluate the PaO2/FiO2 and in the ten minutes a lung ultrasound to evaluate the LUSS. This will be repeated at twenty four and forty eight hours.


Eligibility

Min Age: 17 Years

Inclusion Criteria8

  • \- consent
  • \>17 years old
  • Patient with pathologies leading to chronic IS
  • Chronic Obstructive Pulmonary Disease (COPD) or active asthma
  • Patients under veino-veinous or veino-arterial " Extracorporeal Membrane Oxygenation " (ECMO)
  • Severe trauma patients
  • Less than twenty-four hours post operative patients
  • LUS not feasible: prone position, pneumonectomy history, severe obesity

Exclusion Criteria1

  • LUSS \< 2

Interventions

OTHERLung Ultrasound

Evaluation of the Lung Ultrasound Score in patients presenting an interstitial syndrom on the lung ultrasound and to compare it with PaO2/FiO2


Locations(2)

Centres Hospitaliers de Jolimont

Haine-Saint-Paul, Hainaut, Belgium

Cliniques universitaires saint luc

Brussels, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05631756


Related Trials